Incyte (NASDAQ:INCY) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $71.82, a high estimate of $92.00, and a low estimate of $60.00. This upward trend is evident, with the current average reflecting a 2.73%…